Program

You can access the Interactive Program of WoM 2020 by clicking on the button above.
Below you can find a Program at a Glance.

By registering for the WoMDMH 20 Conference, you will also have access to the co-located World of Microbiome: Pregnancy, Birth & Infancy (WoMPBI 20) Confenrence. Both WoM Conferences will have a common exhibition and networking area, and you will have access to the scientific content of the two tracks and the option to attend WoMPBI 20 sessions and participate in discussions.

To preview the Preliminary program of the WoMPBI 20, please follow this link: https://microbiome-pbi.kenes.com/program/ 

*the Program is Preliminary and is a subject to change.

The Conference will be held in Central European TIme (CET UTC+1).

Please note all live sessions are scheduled in the afternoons, for the convenience of delegates from both Europe and the Americas.

16:00 - 20:30

QIIME2 Workshop

Pre-registration and separate payment is required.

16:00 - 17:00: Introduction to QIIME 2 and microbiome bioinformatics - how can QIIME 2 advance your microbiome research?
17:00 - 18:00: Interacting with core QIIME 2 results: alpha diversity, beta diversity, and taxonomic summaries.
18:00 - 18:30: Break
18:30 - 20:30: Open Question and Answer session (with additional topics of contemporary interest, time permitting)

The Conference will be held in Central European TIme (CET UTC+1).

Please note all live sessions are scheduled in the afternoons, for the convenience of delegates from both Europe and the Americas.

The antibiotic crisis: beyond resistance
Martin Blaser, Rutgers University, USA

Host microbiome interactions in health and disease
Eran Elinav, Weizmann Institute of Science, Israel

Enabling gut microbiome research globally
Gregory Caporaso, Northern Arizona University, USA

Fungi and bacteria in IBD pathogenesis
Harry Sokol, Sorbonne Université, France

The role of genetic factors in shaping the intestinal microbiome - from large-scale GWAS to mQTL studies
Andre Franke, University of Kiel, Germany

The role of the microbiome in causing depression and other psychiatric problems in IBD patients and beyond
Luc Biedermann, University of Zurich, Switzerland

Fatigue, IBD and metabolome
Nynke Borren, Massachusetts General Hospital, USA

TBC

12:00 - 13:30

13:30 - 14:00

Keynote lecture

Microbiome-epithelial interaction and implications
Jonathan Braun, Cedars Sinai Medical Center, USA

The influence of commonly used non-antibiotics on the gut microbiome
Rinse Weersma, University Medical Center Groningen, Netherlands

Factors influencing our microbiome
Eran Segal, Weizmann Institute of Science, Israel

Microbial changes and modification in patients after pouch surgery
Uri Gophna, Tel Aviv University, Israel

Panel Discussion - LIVE FORUM

15:30 - 16:00

Josbert Keller, Haaglanden MC, Netherlands

Alisa Hart, St Mark’s Academic Institute, UK

16:50 - 17:20

Gregory Caporaso, Northern Arizona University, USA

Harry Sokol, Sorbonne Université, France

Andre Franke, University of Kiel, Germany

Nynke Borren, Massachusetts General Hospital, USA

TBC

The Conference will be held in Central European TIme (CET UTC+1).

Please note all live sessions are scheduled in the afternoons, for the convenience of delegates from both Europe and the Americas.

09:00 - 09:30

Keynote lecture

Tumour control
Michael Scharl, University of Zurich, Switzerland

The Microbiome in Primary Sclerosing Cholangitis
Christoph Schramm, University Medical Center Hamburg, Germany

The gut-liver axis in chronic liver diseases
Vanessa Stadlbauer, Medical University of Graz, Austria

Psychosocial factors and microbiota: from hypothesis to facts
Dan Lucian Dumitrascu, University of Medicine and Pharmacy “Iuliu Haţieganu“, Romania

A National Donor Feces Bank for treatment and research beyond Costridioides difficile infections
Ed Kuijper, Leiden University Medical Center, Netherlands

Roots of FMT
Ilan Youngster, Shamir Medical Center, Israel

Gut pathobionts and alcohol-associated liver disease
Bernd Schnabl, University of California San Diego, USA

11:30 - 12:00

Keynote lecture

New forms of intestinal inflammation affected by the microbiome
Iris Dotan, Rabin Medical Center, Israel

12:00 - 13:30

How the microbiome is changed by diet
Lihi Godny, Rabin Medical Center, Israel

Wide-scale antibiotic use for prevention in population-based settings: what would it mean to gut microbiota? The case of H.pylori screen-and-treat strategy
Marcis Leja, University of Latvia, Latvia

Designing diagnostics and therapeutics for the gut microbiome
David Riglar, Imperial College London, UK

Panel Discussion - LIVE FORUM

15:00 - 15:30

15:30 - 16:30

Industry session not included in main event CME/CPD credit

16:30 - 17:00

Christoph Schramm, University Medical Center Hamburg, Germany

Vanessa Stadlbauer, Medical University of Graz, Austria

Dan Lucian Dumitrascu, University of Medicine and Pharmacy “Iuliu Haţieganu“, Romania

Ed Kuijper, Leiden University Medical Center, Netherlands

Ilan Youngster, Shamir Medical Center, Israel

Bernd Schnabl, University of California San Diego, USA

18:00 - 18:30

Topic 1: The importance of clear definitions for probiotics, prebiotics, synbiotics, postbiotics and fermented foods for scientific, commercial and regulatory communities.

Probiotics and fermented foods
Mary Ellen Sanders, Dairy & Food Culture Technologies, USA

Postbiotics
Gabriel Vinderola, National University of Litoral, Argentina

Prebiotics and synbiotics
Glenn Gibson, University of Reading, UK

Topic 2: State of recommendations for these products

“Biotics” for paediatric use
Hania Szajewska, Medical University of Warsaw, Poland

Probiotics for adults
Dan Merenstein, Georgetown University, USA

Panel Discussion - LIVE FORUM

20:30 - 20:40